MedPath

Comparison of the Use of Energy Substrates and Hormonal Regulation of Blood Sugar During Exercise of Increasing Intensity Between Children With Type 1 Diabetes and Non-diabetic Control Children.

Not Applicable
Conditions
Type 1 Diabetes
Interventions
Procedure: controlled physical activity
Registration Number
NCT03139864
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

The type 1 diabetes is a common chronic disease characterised by the stop of production of insulin by the pancreas. A lot of factors modify blood glucose. The objective is to study the effect of type 1 diabetes on the use of energy substrates (fats and carbohydrates) during exercise of increasing intensity by a comparison with non-diabetic controls children.

Detailed Description

The type 1 diabetes is a common chronic disease characterised by the stop of production of insulin by the pancreas. A lot of factors modify blood glucose. The objective is to study the effect of type 1 diabetes on the use of energy substrates (fats and carbohydrates) during exercise of increasing intensity by a comparison with non-diabetic controls children.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
48
Inclusion Criteria
  • Children between 6 and 12 years
  • Tanner stage <T2
  • Type 1 diabetes for more than 1 year for infants with type 1 diabetes
Exclusion Criteria
  • Tanner stage > ou = T2
  • Obesity
  • Hormonal disease
  • Disease who prevent doing exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
type 1 diabetescontrolled physical activityComparison between infants with type 1 diabetes and infants without type 1 diabetes during exercise :
without type 1 diabetescontrolled physical activityComparison between infants with type 1 diabetes and infants without type 1 diabetes during exercise :
Primary Outcome Measures
NameTimeMethod
Comparison of substrate utilization between infants with type 1 diabetes and infants without type 1 diabetes during exerciseat day 1

Measurements will be carried out by indirect calorimetry and the relationship between CO2 et O2 (Metamax)

Secondary Outcome Measures
NameTimeMethod
hormonal regulation of blood glucoseat day 1

insulin, glucagon, adrenaline, cortisol and growth hormone will be metered according to their half life until 2 hours after physical activity (T12, T20, T40, T60, T120)

lipoxmax : the intensity for wich lipid oxydation is maximum will be carried out by indirect calorimetryat day 1

during exercise

Comparison between infants during 10 days before and 4 days after exercise of blood glucose modification10 days before and 4 days after exercise of blood glucose modification

Comparison of curves of interstitial blood glucose measured with Freestyle®

Trial Locations

Locations (1)

CHU Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath